Evidence map›Paper›PMID 41491074›Full record

ArticleBritish journal of pharmacology2026

FM-dye inhibition of Piezo2 relieves mechanically evoked pain in mouse models of acute inflammatory and osteoarthritic knee pain.

Natalie S Adamczyk, Shingo Ishihara, Alia M Obeidat, Daniel B Hoffman, Brian T David, Dongjun Ren, Richard J Miller, Anne-Marie Malfait, Rachel E Miller

Abstract read
In one paragraph

Article in British journal of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Natalie S AdamczykDepartment of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, Illinois, USA.
Shingo IshiharaDepartment of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, Illinois, USA.
Alia M ObeidatDepartment of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, Illinois, USA.
Daniel B HoffmanDepartment of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, Illinois, USA.
Brian T DavidDepartment of Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA.
Dongjun RenChicago Center on Musculoskeletal Pain, Chicago, Illinois, USA.
Richard J MillerChicago Center on Musculoskeletal Pain, Chicago, Illinois, USA.
Anne-Marie MalfaitDepartment of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, Illinois, USA.
Rachel E MillerDepartment of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, Illinois, USA.

Funding

Osteoarthritis Progression And Sensory Pathway AlterationsR01AR064251 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI MALFAIT, ANNE-MARIE, MILLER, RICHARD J · 2013 to 2025
$7.6M
Molecular Pathways of Pain Generation in OsteoarthritisR01AR060364 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI MALFAIT, ANNE-MARIE · 2011 to 2025
$6.0M
Neurobiology Core CP30AR079206 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI Anne-Marie Malfait · 2021 to 2026
$4.7M
The Role of Mechanosensation Pathways in Osteoarthritis Joint Damage and PainR01AR077019 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI Rachel Elizabeth Miller · 2021 to 2026
$2.7M
Pre and Post-Doctoral Training in Joint HealthT32AR073157 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI D Rick Sumner · 2019 to 2026
$2.3M
Piezo2-mediated neuroplasticity in osteoarthritisF31AR083277 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI ADAMCZYK, NATALIE · 2023 to 2024
$90k
NIAMS NIH HHS F31 AR083277NIAMS NIH HHS F31AR083277NIAMS NIH HHS P30 AR079206NIAMS NIH HHS P30AR079206NIAMS NIH HHS R01 AR060364NIAMS NIH HHS R01AR060364NIAMS NIH HHS R01 AR064251NIAMS NIH HHS R01AR064251NIAMS NIH HHS R01 AR077019NIAMS NIH HHS R01AR077019NIAMS NIH HHS R01AR077019-03S1NIAMS NIH HHS T32 AR073157NIAMS NIH HHS T32AR073157
6 · The paper itself

Abstract

background and purposeMusculoskeletal pain is a significant burden with limited pain relief options. The mechanically activated ion channel Piezo2 plays a role in mechanical sensitization; however, there has been little progress in examining therapeutics that target Piezo2. The goal of this study was to assess the effectiveness of FM-dye in reducing acute inflammatory and osteoarthritic (OA) knee pain in mice through Piezo2. EXPERIMENTAL APPROACH: Wild-type or nociceptor-specific Piezo2 conditional knockout (Piezo2cko) mice were used. The complete Freund's adjuvant (CFA) model of acute inflammatory knee pain, the partial medial meniscectomy (PMX) OA model, and ageing-associated OA mouse models were used. Pain-related behaviours (knee hyperalgesia, weight bearing asymmetry) were established prior to intra-articular injection of FM-dye (5 nmol in 2.5 μl) or vehicle. In vivo calcium imaging of the L4 dorsal root ganglion (DRG) was performed using Na KEY

resultsIn the CFA model, female and male mice intra-articularly injected with FM1-43 exhibited reduced knee hyperalgesia 90 min post-injection. In vivo calcium imaging of the DRG demonstrated a reduction in nociceptor responses to mechanical force applied to the knee of CFA mice following FM-dye. Following PMX, intra-articular injection of FM1-43 reduced knee hyperalgesia in wild-type mice but not in Piezo2cko mice; weight bearing asymmetry was also reduced. In mice with age-associated OA, intra-articular injection of FM-dyes reduced knee hyperalgesia. CONCLUSION AND IMPLICATIONS: Inhibiting Piezo2 pharmacologically reduced pain-related behaviours in mouse models of inflammatory and OA knee pain, providing evidence of the therapeutic potential of targeting Piezo2.

Indexed as

nociceptorosteoarthritispainPiezo2sensitization

Identifiers

PMID41491074
PMCPMC12879056

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.